Overview

  • Product nameRhodadyn™ B10
  • Description
    Negative control for Rhodadyn™ C10 (ab120795)
  • Biological descriptionNegative control for Rhodadyn™ C10 (ab120795). Demonstrates no significant inhibition of dynamin I or dynamin II in vitro GTPase activity at concentrations up to 300 μM and has no effect on clathrin-mediated endocytosis of transferrin when applied for 30 minutes to U2OS cells in culture.

    Robertson J et al. The rhodadyn™ a new class of small molecule inhibitors of dynamin GTPase. ACS Med. Chem (2012).
  • Purity> 95%
  • General notesSold under exclusive licence from Children's Medical Research Institute and Newcastle Innovations Ltd. Rhodadyn™ is a trademark of Children's Medical Research Institute and Newcastle Innovation Ltd.

Properties

    References for Rhodadyn™ B10 (ab120796)

    ab120796 has not yet been referenced specifically in any publications.

    Product Wall

    There are currently no Abreviews or Questions for ab120796.
    Please use the links above to contact us or submit feedback about this product.

    Please note: All products are "FOR RESEARCH USE ONLY AND ARE NOT INTENDED FOR DIAGNOSTIC OR THERAPEUTIC USE, NOT FOR USE IN HUMANS"